Vendeur : Basi6 International, Irving, TX, Etats-Unis
EUR 107,99
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 85,07
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Gut. Zustand: Gut | Sprache: Englisch | Produktart: Bücher | Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Vendeur : Buchpark, Trebbin, Allemagne
EUR 87,87
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 225,62
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Vendeur : preigu, Osnabrück, Allemagne
EUR 184,85
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Appropriate Dose Selection - How to Optimize Clinical Drug Development | J. Venitz (u. a.) | Taschenbuch | Ernst Schering Foundation Symposium Proceedings | xvi | Englisch | 2014 | Springer | EAN 9783642421761 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 277,35
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2006
ISBN 10 : 3540278672 ISBN 13 : 9783540278672
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 213,99
Quantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers - based on the (known) pharmacology of the drug and/or biology of the underlying disease - along with exposure-response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 221,53
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers - based on the (known) pharmacology of the drug and/or biology of the underlying disease - along with exposure-response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 318,66
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Like New. Like New. book.
Langue: anglais
Edité par Springer Berlin Heidelberg Nov 2014, 2014
ISBN 10 : 3642421768 ISBN 13 : 9783642421761
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 123,04
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents. 240 pp. Englisch.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 166,29
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2014
ISBN 10 : 3642421768 ISBN 13 : 9783642421761
Vendeur : moluna, Greven, Allemagne
EUR 180,07
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agentsOptimal dose individualization has become more important in improving clinical efficacy and safety, given the variability.
Langue: anglais
Edité par Springer Berlin Heidelberg, 2006
ISBN 10 : 3540278672 ISBN 13 : 9783540278672
Vendeur : moluna, Greven, Allemagne
EUR 180,07
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agentsOptimal dose individualization has become more important in improving clinical efficacy and safety, given the variability.
Langue: anglais
Edité par Springer Berlin Heidelberg Okt 2006, 2006
ISBN 10 : 3540278672 ISBN 13 : 9783540278672
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 213,99
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents. 240 pp. Englisch.
Vendeur : preigu, Osnabrück, Allemagne
EUR 186,70
Quantité disponible : 5 disponible(s)
Ajouter au panierBuch. Etat : Neu. Appropriate Dose Selection - How to Optimize Clinical Drug Development | J. Venitz (u. a.) | Buch | xvi | Englisch | 2006 | Springer | EAN 9783540278672 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Langue: anglais
Edité par Springer, J.B. Metzler Nov 2014, 2014
ISBN 10 : 3642421768 ISBN 13 : 9783642421761
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 213,99
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.
Langue: anglais
Edité par Springer, Springer Okt 2006, 2006
ISBN 10 : 3540278672 ISBN 13 : 9783540278672
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 213,99
Quantité disponible : 1 disponible(s)
Ajouter au panierBuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.
Vendeur : Majestic Books, Hounslow, Royaume-Uni
EUR 296,58
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. Print on Demand.
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 294,39
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. PRINT ON DEMAND.